KKR to buy medical device firm Integer Holdings for $5.7 billion
Aug 3 (Reuters) - Private equity giant KKR will buy Integer Holdings in an all-cash deal valued at $5.7 billion, the medical-device outsourcing firm said on Monday. Under the terms of the agreement, KKR will offer $127 per share for the company, implying a 4.78% premium to Integer’s last close on Friday.
Reported by 1 outlet — Investing.com · Stock Market. See all sources ↓
Aug 3 (Reuters) - Private equity giant KKR will buy Integer Holdings in an all-cash deal valued at $5.7 billion, the medical-device outsourcing firm said on Monday. Under the terms of the agreement, KKR will offer $127 per share for the company, implying a 4.78% premium to Integer’s last close on Friday. Shares of Plano, Texas-based Integer Holdings rose 2% in premarket trading. Through the buyout, KKR will gain a company that makes critical components and devices used in heart treatments, pain management therapies and other medical technologies for many of the world’s leading medical device manufacturers.
Read the full report at Investing.com · Stock Market ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- Aug 3 (Reuters) - Private equity giant KKR will buy Integer Holdings in an all-cash deal valued at $5.7 billion, the medical-device outsourcing firm said on Monday. Under the terms of the agreement, KKR will offer $127 per share for the company, implying a 4.78% premium to Integer’s last close on Friday.
- How widely is it covered?
- 1 outlet, average source rating 6.0/10.
- When was it last updated?
- 5m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
KKR to buy medical device firm Integer Holdings for $5.7 billion
Sources1TypeCoverageInvesting.com · Stock Market